FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/09/2022
Back to search
Official data from USPTO
CAPTIXBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CAPTIXBIO
ST13
US500000079303443Class
5, 10
Filing
79303443
Registration
6635082
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/09/2022
Trademark type
Word
Nice classes
5, 10
Filing date
11/03/2020
Registration date
02/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/08/2022
Last transaction
02/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
AU
Examiner
VAGHANI, MAYUR C
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Captix Biomedical Pty Ltd
Representatives
Charles G. Zug Nelson Mullins Riley & Scarborough LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Bone implants comprising living tissue; biological bone implant material comprising living tissue; surgical implants comprised of living tissues; cell therapiesliving cells for medical usestem cells for medical useendocrine progenitor cells for medical use; pharmaceutical preparations for restoration of endocrine function and metabolic control; pharmaceutical products for restoration of endocrine function and metabolic control; cells for medical use; cells for medical purposes; stem cells for medical purposes; endocrine progenitor cells for medical use; therapeutic medical drugs for restoration of endocrine function and metabolic control; preparations for medical purposesbone implants incorporating living cells for medical purposes
Class 10
Bone implants comprising artificial materials; immuno-protective devicesimplants made of artificial materials; implantable medical devicesmedicalsurgical and orthopaedic implants made of artificial materials; implantable medical devices with an immune-protective functionimplants consisting primarily of artificial materials and also including biological materials; implantable devices for the delivery of automatic medicationimplants consisting primarily of artificial materials; implantable devices for medical use in measuring the composition of body fluids; medical implants made of artificial materials; orthopaedic implants of artificial materials; artificial implants; medical apparatus and instruments for use in orthopaedic medical procedures; cell culture apparatus for medical useimplantable cell culture chambers; drug delivery apparatusdevices carrying cells for the delivery of drugsimplantable devices carrying cells for the delivery of drugscell cargo carriers for the delivery of drugs
Publications
History of USPTO decisions and trademark events.
24 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/15/2022
FIMP
FINAL DISPOSITION PROCESSED
07/15/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/08/2022
GPNX
NOTIFICATION PROCESSED BY IB
12/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/23/2021
PUBO
PUBLISHED FOR OPPOSITION
11/23/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/17/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/17/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/21/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/19/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/19/2021
RFNT
REFUSAL PROCESSED BY IB
05/11/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/19/2021
RFRR
REFUSAL PROCESSED BY MPU
04/19/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/14/2021
CNRT
NON-FINAL ACTION WRITTEN
04/13/2021
DOCK
ASSIGNED TO EXAMINER
04/08/2021
MAFR
APPLICATION FILING RECEIPT MAILED
02/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/04/2021
Continuous trademark protection
Get notified about every new filing that threatens CAPTIXBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.